skip to Main Content

Research Provides Guidance for Treating Pancreatic Cancer Patients During COVID-19 Pandemic

Newsfeed image, light gray text on dark gray background
The novel coronavirus (COVID-19) pandemic not only affects patients who have the virus, but strikes the entire healthcare system including the care for patients with cancer. Aggressive cancers, such as pancreatic cancer, require the continuation of oncological care during the pandemic. However, pursuing care exposes both healthcare professionals and vulnerable patients to COVID-19.

Today, new research published in Annals of Surgery from the University of Colorado Department of Surgery at the Anschutz Medical Campus provides guidance on clinical decision-making in regards to treating pancreatic cancer patients during the COVID-19 pandemic. Read more . . . 

Back To Top